Trump and Kennedy Reveal Initiative to Curb Direct-to-Consumer Pharmaceutical Advertising
Tackling Deceptive Drug Advertisements: A New Push for Transparency The pharmaceutical advertising landscape is changing. Recently, President Trump instructed Health Secretary Robert F. Kennedy Jr. to take action against misleading direct-to-consumer drug ads. This decision comes at a time when the Food and Drug Administration (FDA) is stepping up its enforcement against deceptive advertising practices. …